About adyn
adyn is a company based in Seattle (United States) founded in 2019. adyn has raised $2.65 million across 2 funding rounds from investors including Lux Capital, M13 Company and Civilization Ventures. adyn offers products and services including Birth Control Test and Quiz and Consultation. adyn operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.65 M (USD)
in 2 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Apr 19, 2021
-
Investors
Lux Capital
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of adyn
adyn offers a comprehensive portfolio of products and services, including Birth Control Test and Quiz and Consultation.
At-home kit for analyzing hormones and genetics to recommend side-effect-free birth control.
Interactive quiz providing personalized birth control recommendations and virtual provider visits.
People of adyn
Unlock access to complete
Unlock access to complete
Funding Insights of adyn
adyn has successfully raised a total of $2.65M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in adyn
adyn has secured backing from 11 investors, including venture fund and angel investors. Prominent investors backing the company include Lux Capital, M13 Company and Civilization Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by M13 venture capital fund.
|
Locked | Locked | Locked | |
|
Venture capital is provided to health tech and biology innovations.
|
Locked | Locked | Locked |
Investor details for adyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by adyn
Investment portfolio details for adyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - adyn
Detailed financials for adyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adyn Comparisons
Peer comparison for adyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of adyn
adyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
Genomic testing services are provided clinically and directly to consumers.
|
|
| Locked | Locked | Locked |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| Locked | Locked | Locked |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
|
| Locked | Locked | Locked |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
Detailed competitors of adyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adyn
Complete news archive for adyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about adyn
adyn was founded in 2019 and raised its 1st funding round 1 year after it was founded.
adyn is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
adyn is a funded company, having raised a total of $2.65M across 2 funding rounds to date.
Provider of DNA and hormone analysis-based birth control optimization kits. The company offers collection kits (DNA sample and hormone sample), in which users can collect the sample as directed and the company offers an online personalized questionnaire for personal details for hormonal and genetic profile analysis to generate customized birth control recommendations which are further reviewed by a physician and delivered via data servers. The report also offers the medical biography with the side effect profiles, the company also offers the analysis of genetic predisposition, 4 synthetic estrogens, and 12 synthetic progestins.
adyn's top competitors include Strand Life Sciences, Fulgent Genetics and Centogene.
adyn offers Birth Control Test and Quiz and Consultation.
adyn has 11 investors. Key investors include Lux Capital, M13 Company, Civilization Ventures, Westbound, and Y Combinator.